A low-tech analytical method for diethylcarbamazine citrate in medicated salt

The World Health Organization has called for an effort to eliminate Lymphatic Filariasis (LF) around the world. In regions where the disease is endemic, local production and distribution of medicated salt dosed with diethylcarbamazine (DEC) has been an effective method for eradicating LF. A partner of the Notre Dame Haiti program, Group SPES in Port-au-Prince, Haiti, produces a medicated salt called Bon Sel. Coarse salt is pre-washed and sprayed with a solution of DEC citrate and potassium iodate. Iodine levels are routinely monitored on site by a titrimetric method. However, the factory had no method for monitoring DEC. Critical analytical issues include 1) determining whether the amount of DEC in each lot of Bon Sel is within safe and therapeutically useful limits, 2) monitoring variability within and between production runs, and 3) determining the effect of a common local practice (washing salt before use) on the availability of DEC. This paper describes a novel titrimetric method for analysis of DEC citrate in medicated salt. The analysis needs no electrical power and requires only a balance, volumetric glassware, and burets that most salt production programs have on hand for monitoring iodine levels. The staff of the factory used this analysis method on site to detect underloading of DEC on the salt by their sprayer and to test a process change that fixed the problem.     

Pathways activated during human asthma exacerbation as revealed by gene expression patterns in blood

Background

Asthma exacerbations remain a major unmet clinical need. The difficulty in obtaining airway tissue and bronchoalveolar lavage samples during exacerbations has greatly hampered study of naturally occurring exacerbations. This study was conducted to determine if mRNA profiling of peripheral blood mononuclear cells (PBMCs) could provide information on the systemic molecular pathways involved during asthma exacerbations.

Methodology/Principal Findings

Over the course of one year, gene expression levels during stable asthma, exacerbation, and two weeks after an exacerbation were compared using oligonucleotide arrays. For each of 118 subjects who experienced at least one asthma exacerbation, the gene expression patterns in a sample of peripheral blood mononuclear cells collected during an exacerbation episode were compared to patterns observed in multiple samples from the same subject collected during quiescent asthma. Analysis of covariance identified genes whose levels of expression changed during exacerbations and returned to quiescent levels by two weeks. Heterogeneity among visits in expression profiles was examined using K-means clustering. Three distinct exacerbation-associated gene expression signatures were identified. One signature indicated that, even among patients without symptoms of respiratory infection, genes of innate immunity were activated. Antigen-independent T cell activation mediated by IL15 was also indicated by this signature. A second signature revealed strong evidence of lymphocyte activation through antigen receptors and subsequent downstream events of adaptive immunity. The number of genes identified in the third signature was too few to draw conclusions on the mechanisms driving those exacerbations.

Conclusions/Significance

This study has shown that analysis of PBMCs reveals systemic changes accompanying asthma exacerbation and has laid the foundation for future comparative studies using PBMCs.     

Cortactin: A multifunctional regulator of cellular invasiveness

Branched actin assembly is critical for a variety of cellular processes that underlie cell motility and invasion, including cellular protrusion formation and membrane trafficking. Activation of branched actin assembly occurs at various subcellular locations via site-specific activation of distinct WASp family proteins and the Arp2/3 complex. A key branched actin regulator that promotes cell motility and links signaling, cytoskeletal and membrane trafficking proteins is the Src kinase substrate and Arp2/3 binding protein cortactin. Due to its frequent overexpression in advanced, invasive cancers and its general role in regulating branched actin assembly at multiple cellular locations, cortactin has been the subject of intense study. Recent studies suggest that cortactin has a complex role in cellular migration and invasion, promoting both on-site actin polymerization and modulation of autocrine secretion. Diverse cellular activities may derive from the interaction of cortactin with site-specific binding partners.Key words: cortactin, migration, invasion, lamellipodia, invadopodia, cancer, actin, actin assembly, scaffold, membrane trafficking, secretion     

Structural and Functional Studies of Truncated Hemolysin A from Proteus mirabilis

In this study we analyzed the structure and function of a truncated form of hemolysin A (HpmA265) from Proteus mirabilis using a series of functional and structural studies. Hemolysin A belongs to the two-partner secretion pathway. The two-partner secretion pathway has been identified as the most common protein secretion pathway among Gram-negative bacteria. Currently, the mechanism of action for the two-partner hemolysin members is not fully understood. In this study, hemolysis experiments revealed a unidirectional, cooperative, biphasic activity profile after full-length, inactive hemolysin A was seeded with truncated hemolysin A. We also solved the first x-ray structure of a TpsA hemolysin. The truncated hemolysin A formed a right-handed parallel β-helix with three adjoining segments of anti-parallel β-sheet. A CXXC disulfide bond, four buried solvent molecules, and a carboxyamide ladder were all located at the third complete β-helix coil. Replacement of the CXXC motif led to decreased activity and stability according to hemolysis and CD studies. Furthermore, the crystal structure revealed a sterically compatible, dry dimeric interface formed via anti-parallel β-sheet interactions between neighboring β-helix monomers. Laser scanning confocal microscopy further supported the unidirectional interconversion of full-length hemolysin A. From these results, a model has been proposed, where cooperative, β-strand interactions between HpmA265 and neighboring full-length hemolysin A molecules, facilitated in part by the highly conserved CXXC pattern, account for the template-assisted hemolysis.Hemolysin A (HpmA)² and B (HpmB) from Proteus mirabilis belong to the Type V_b or two-partner secretion pathway (1), the most widespread of the five porin-type protein translocating systems found within bacterial, fungal, plant, and animal kingdoms (2). Cell surface adhesions, iron-acquisition proteins, and cytolysins/hemolysins all use two-partner secretion pathways (3–5). The A-component of the two-partner secretion in P. mirabilis is a 166-kDa virulence factor capable of mammalian blood cell lysis upon secretion from the cell. This is accomplished by Sec-dependent transport to the periplasm followed by N-terminal proteolytic processing. Extracellular secretion occurs by transport through the B-component, HpmB, which is a 16-stranded β-barrel transmembrane channel (6). In addition to its role in efficient secretion, HpmB is also necessary for activation of the larger exoprotein A-component (HpmA) (7–10).Studies on hemolytic TpsA members report that: 1) a truncated TpsA containing the N-terminal secretion cap (11) complements and restores hemolytic activity within a non-secreted/inactive pool of full-length TpsA (12), 2) the conserved cysteine residues within a CXXC motif are not required for secretion (12), and 3) the first asparagine within a NPNG hemagglutinin motif is required for efficient secretion (13). Other investigations demonstrate significant conformational change within TpsA members during B-component dependent secretion (8, 14–16).Recent x-ray crystal structures for two TpsA adhesion orthologs, hemagglutinin from Bordetella pertussis (FHA) and high molecular weight protein from Haemophilus influenzae (HMW1) adopt a right-handed parallel β-helix similar to pectate lyase (11, 18, 19). The 301-residue N-terminal FHA fragment (Fha30) contains a 37 parallel stranded β-helix. Stabilization of type I β-turns at two highly conserved regions: ⁶⁶NPNL and ¹⁰⁵NPNG is proposed to play a large role in the ability of this N-terminal fragment to rapidly adopt β-helix architecture (11, 20). Despite 21% sequence identity, the 371-residue HMW1 structure (HMW1-PP) is a similar 47 parallel stranded β-helix. A hypothesis arose from these β-helix structures that suggests extracellular secretion through TpsB channels, and the progressive folding of TpsA members is energetically coupled. Full-length TpsA adhesion members have been proposed to have a filamentous appearance built from a right-handed β-helix fold (21). To date, there is little known about the full-length HpmA domain architecture. However, there are two filamentous hemagglutinin type domains. The N-terminal domain is positioned between residues 30 and 167, whereas the C-terminal domain lies between residues 1200 and 1264 and has been proposed to facilitate cellular aggregation.In this work, we investigated the functional and structural role of truncated hemolysin A (HpmA265) during the template-assisted activation of hemolysis. A previous investigation with ShlA, a homologous TpsA member from Serratia marcescens, has shown similar complementation using a 255-amino acid fragment (12). Here, we demonstrate that HmpA265 can cooperatively cross seed an inactive pool of full-length hemolysin A (HpmA*) to form an exotoxin measured by our template-assisted hemolytic assay (TAHA). We also report that the CXXC motif provides structural stability and facilitates reversible re-folding. The structure reveals a right-handed β-helix, similar to those of FHA and HMW1. A number of conserved features found at the putative subunit interface suggest a mechanism by which activation of inactive HpmA* occurs.     

Discovery and SAR of 6-substituted-4-anilinoquinazolines as non-competitive antagonists of mGlu5

A high-throughput cell-based screen identified a series of 6-substituted-4-anilinoquinazolines as non-competitive antagonists of metabotropic glutamate receptor 5 (mGlu₅). This Letter describes the SAR of this series and the profile of selected compounds in selectivity and radioligand binding assays.     

Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4)

This Letter describes the synthesis and SAR of the novel positive allosteric modulator, VU0155041, a compound that has shown in vivo efficacy in rodent models of Parkinson’s disease. The synthesis takes advantage of an iterative parallel synthesis approach to rapidly synthesize and evaluate a number of analogs of VU0155041.     

A biased ligand for OXE-R uncouples Gα and Gβγ signaling within a heterotrimer

Differential targeting of heterotrimeric G protein versus β-arrestin signaling are emerging concepts in G protein-coupled receptor (GPCR) research and drug discovery, and biased engagement by GPCR ligands of either β-arrestin or G protein pathways has been disclosed. Herein we report on a new mechanism of ligand bias to titrate the signaling specificity of a cell-surface GPCR. Using a combination of biomolecular and virtual screening, we identified the small-molecule modulator Gue1654, which inhibits Gβγ but not Gα signaling triggered upon activation of Gα(i)-βγ by the chemoattractant receptor OXE-R in both recombinant and human primary cells. Gue1654 does not interfere nonspecifically with signaling directly at or downstream of Gβγ. This hitherto unappreciated mechanism of ligand bias at a GPCR highlights both a new paradigm for functional selectivity and a potentially new strategy to develop pathway-specific therapeutics.